343 related articles for article (PubMed ID: 23109824)
21. How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?
Sainz-Ramos M; Gallego I; Villate-Beitia I; Zarate J; Maldonado I; Puras G; Pedraz JL
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299164
[TBL] [Abstract][Full Text] [Related]
22. Inhaled gene therapy in lung cancer: "as for the future, our task is not to foresee it, but to enable it".
Zarogoulidis P; Kontakiotis T; Zarogoulidis K
Ther Deliv; 2012 Aug; 3(8):919-21. PubMed ID: 22946426
[No Abstract] [Full Text] [Related]
23. Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery.
Wang H; Qin L; Zhang X; Guan J; Mao S
J Control Release; 2022 Dec; 352():970-993. PubMed ID: 36372386
[TBL] [Abstract][Full Text] [Related]
24. Graphene materials as 2D non-viral gene transfer vector platforms.
Vincent M; de Lázaro I; Kostarelos K
Gene Ther; 2017 Mar; 24(3):123-132. PubMed ID: 27874854
[TBL] [Abstract][Full Text] [Related]
25. Modification of mutant K-ras gene expression in non-small cell lung cancer (NSCLC).
Roth JA
Hum Gene Ther; 1996 May; 7(7):875-89. PubMed ID: 9147520
[No Abstract] [Full Text] [Related]
26. Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice.
Minai-Tehrani A; Chang SH; Kwon JT; Hwang SK; Kim JE; Shin JY; Yu KN; Park SJ; Jiang HL; Kim JH; Hong SH; Kang B; Kim D; Chae CH; Lee KH; Beck GR; Cho MH
Cell Oncol (Dordr); 2013 Feb; 36(1):15-26. PubMed ID: 23070870
[TBL] [Abstract][Full Text] [Related]
27. Topical gene therapy for pulmonary diseases with PEI-DNA aerosol complexes.
Gautam A; Waldrep JC; Orson FM; Kinsey BM; Xu B; Densmore CL
Methods Mol Med; 2003; 75():561-72. PubMed ID: 12407764
[No Abstract] [Full Text] [Related]
28. Aerosol Delivery in the Treatment of Lung Cancer.
Storti C; Le Noci V; Sommariva M; Tagliabue E; Balsari A; Sfondrini L
Curr Cancer Drug Targets; 2015; 15(7):604-12. PubMed ID: 26033086
[TBL] [Abstract][Full Text] [Related]
29. Genetic therapies for cystic fibrosis lung disease.
Sinn PL; Anthony RM; McCray PB
Hum Mol Genet; 2011 Apr; 20(R1):R79-86. PubMed ID: 21422098
[TBL] [Abstract][Full Text] [Related]
30. Production of clinical-grade recombinant adeno-associated virus vectors.
Snyder RO; Flotte TR
Curr Opin Biotechnol; 2002 Oct; 13(5):418-23. PubMed ID: 12459331
[TBL] [Abstract][Full Text] [Related]
31. Inhaled chemotherapy in lung cancer: future concept of nanomedicine.
Zarogoulidis P; Chatzaki E; Porpodis K; Domvri K; Hohenforst-Schmidt W; Goldberg EP; Karamanos N; Zarogoulidis K
Int J Nanomedicine; 2012; 7():1551-72. PubMed ID: 22619512
[TBL] [Abstract][Full Text] [Related]
32. Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium.
Manunta MD; McAnulty RJ; Tagalakis AD; Bottoms SE; Campbell F; Hailes HC; Tabor AB; Laurent GJ; O'Callaghan C; Hart SL
PLoS One; 2011; 6(10):e26768. PubMed ID: 22046351
[TBL] [Abstract][Full Text] [Related]
33. [Current status and prospect of lung cancer gene therapy].
Zu L; Liu H; Chen J; Zhou Q
Zhongguo Fei Ai Za Zhi; 2011 Sep; 14(9):758-62. PubMed ID: 21924046
[No Abstract] [Full Text] [Related]
34. Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers.
Hoyos V; Del Bufalo F; Yagyu S; Ando M; Dotti G; Suzuki M; Bouchier-Hayes L; Alemany R; Brenner MK
Mol Ther; 2015 Sep; 23(9):1497-506. PubMed ID: 26084970
[TBL] [Abstract][Full Text] [Related]
35. Self-entanglement of long linear DNA vectors using transient non-B-DNA attachment points: a new concept for improvement of non-viral therapeutic gene delivery.
Tolmachov OE
Med Hypotheses; 2012 May; 78(5):632-5. PubMed ID: 22356834
[TBL] [Abstract][Full Text] [Related]
36. Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
Alton EW; Boyd AC; Cheng SH; Davies JC; Davies LA; Dayan A; Gill DR; Griesenbach U; Higgins T; Hyde SC; Innes JA; McLachlan G; Porteous D; Pringle I; Scheule RK; Sumner-Jones S
Gene Ther; 2014 Jan; 21(1):89-95. PubMed ID: 24196086
[TBL] [Abstract][Full Text] [Related]
37. Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives.
Ediriweera GR; Chen L; Yerbury JJ; Thurecht KJ; Vine KL
Mol Pharm; 2021 Jun; 18(6):2142-2160. PubMed ID: 34010004
[TBL] [Abstract][Full Text] [Related]
38. Research Progress of nucleic acid delivery vectors for gene therapy.
Jiao Y; Xia ZL; Ze LJ; Jing H; Xin B; Fu S
Biomed Microdevices; 2020 Jan; 22(1):16. PubMed ID: 31989315
[TBL] [Abstract][Full Text] [Related]
39. A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer.
Tagalakis AD; McAnulty RJ; Devaney J; Bottoms SE; Wong JB; Elbs M; Writer MJ; Hailes HC; Tabor AB; O'Callaghan C; Jaffe A; Hart SL
Mol Ther; 2008 May; 16(5):907-15. PubMed ID: 18388925
[TBL] [Abstract][Full Text] [Related]
40. A non-viral vector for in vivo gene delivery.
Thomas L
Lancet Neurol; 2005 Oct; 4(10):602. PubMed ID: 16208875
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
